Visceral leishmaniasis other diagnostic studies

Visceral leishmaniasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Visceral Leishmaniasis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Visceral leishmaniasis other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Visceral leishmaniasis other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Visceral leishmaniasis other diagnostic studies
CDC on Visceral leishmaniasis other diagnostic studies
Visceral leishmaniasis other diagnostic studies in the news
Blogs on Visceral leishmaniasis other diagnostic studies
Directions to Hospitals Treating Visceral leishmaniasis
Risk calculators and risk factors for Visceral leishmaniasis other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other tests being developed include a latex agglutination test (KAtex), which is currently being tested in Asia and Africa. Another potential test detects erythrosalicylic acid.

References

Template:WikiDoc Sources